Cumberland PharmaceuticalsCPIX
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 30 institutions reported holding Cumberland Pharmaceuticals (CPIX) in their 13F filings, down 1 from Q2 2025. 3 opened new positions and 4 sold out. The largest holders were Millennium Management ($1.9M), Ikarian Capital, LLC ($1.7M) and Renaissance Technologies ($1.6M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Cumberland Pharmaceuticals
- CUSIP
- 230770109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $3K |
| Exits | 4 | $122K |
All 13F filers, Q2 2025 → Q3 2025: 57,413 shares bought and 332,626 shares sold, net −275,213 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 30 holders
| Millennium Management | 0.00% | Reduce -22.9% | 598,634 | $1.9M |
| Ikarian Capital, LLC | 0.35% | Reduce -6.7% | 555,932 | $1.7M |
| Renaissance Technologies | 0.00% | Add +4.1% | 515,465 | $1.6M |
| Vanguard Group Inc. | 0.00% | No change | 411,786 | $1.3M |
| Dimensional Fund Advisors LP | 0.00% | Add +11.1% | 280,869 | $876K |
| J. Goldman & Co LP | 0.02% | Reduce -5.7% | 208,143 | $649K |
| Bridgeway Capital Management, LLC | 0.01% | No change | 188,355 | $588K |
| Boothbay Fund Management, LLC | 0.01% | Reduce -6.7% | 168,132 | $525K |
| Geode Capital Management, LLC | 0.00% | Add +1.4% | 101,621 | $317K |
| Bank of New York Mellon Corp | 0.00% | No change | 72,513 | $226K |
| BlackRock, Inc. | 0.00% | Add +1.9% | 52,129 | $163K |
| Acadian Asset Management LLC | 0.00% | No change | 44,288 | $138K |
| Citadel Advisors | 0.00% | Reduce -44.3% | 41,445 | $129K |
| Two Sigma Investments, LP | 0.00% | Add +16.5% | 37,591 | $117K |
| State Street Corp. | 0.00% | No change | 33,700 | $105K |
| Heron Bay Capital Management | 0.02% | Reduce -4.8% | 31,664 | $99K |
| Northern Trust Corp. | 0.00% | No change | 19,603 | $61K |
| Cresset Asset Management, LLC | 0.00% | No change | 18,475 | $58K |
| XTX Topco Ltd | 0.00% | Add +3.0% | 10,591 | $33K |
| Group One Trading LLC | 0.00% | Reduce -5.8% | 7,742 | $24K |
| Morgan Stanley | 0.00% | Reduce -70.9% | 3,605 | $11K |
| UBS Group AG | 0.00% | Reduce -90.6% | 827 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -62.6% | 787 | $2K |
| NewEdge Advisors, LLC | 0.00% | Reduce -47.1% | 756 | $2K |
| Jones Financial Companies LLLP | 0.00% | New | 600 | $2K |
| Farther Finance Advisors, LLC | 0.00% | New | 345 | $1K |
| Capital Advisors, Ltd. LLC | 0.00% | No change | 437 | $1K |
| Bank of America Corp. | 0.00% | Reduce -81.9% | 17 | $53 |
| Citigroup Inc. | 0.00% | New | 4 | $12 |
| Huntington National Bank | 0.00% | No change | 1 | $3 |
"% of holder's portfolio" is CPIX's weight in each manager's 13F, not the share of Cumberland Pharmaceuticals the manager owns.